Top cancer research institutions split $540M windfall

Memorial Sloan-Kettering Cancer Center in New York now has an extra $90 million to devote to cancer immunotherapy research. The center was one of 6 top institutions to split a major $540 million offering from Ludwig Cancer Research. MIT will use its money to explore metastasis with Harvard, Stanford will focus on cancer stem cells, the University of Chicago will research hormone and radiation-based therapies and Johns Hopkins will concentrate on prevention and early detection. Story

Suggested Articles

An inhaled drug developed by Aridis eradicated the novel coronavirus from infected hamsters at a much lower dose than other antibody treatments.

The financing positions SparingVision to fund clinical trials of an AAV gene therapy that could stop vision deterioration in 2 million patients.

The biotech behind AstraZeneca and the University of Oxford’s late-stage pandemic vaccine has hired Margaret (Meg) Marshall, M.D., as its new CMO.